Lupin Recalls Escitalopram 20 mg Due to Labeling Errors
Lupin Limited recalls 3,192 bottles of Escitalopram Tablets USP 20 mg because labels have incorrect or missing lot and expiration dates.
Lower-risk recall
Labeling: Incorrect or Missing Lot and/or Expiration Date
Contact the company
What happened, in plain English
Lupin Limited is recalling 3,192 bottles of Escitalopram Tablets USP 20 mg manufactured in India. The recall addresses labeling issues where the lot number and/or expiration date are incorrect or missing from the packaging. This affects specific bottles distributed nationwide before March 24, 2016. Read more at govinfonow.com/recall/43098-lupin-recalls-escitalopram-20-mg-due-to-labeling-errors.
Source Summary by GovInfoNow · govinfonow.com/recall/43098-lupin-recalls-escitalopram-20-mg-due-to-labeling-errors · Updated October 11, 2026 · FDA enforcement record: FDA #D-1516-201
Cite this page
“Lupin Recalls Escitalopram 20 mg Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43098-lupin-recalls-escitalopram-20-mg-due-to-labeling-errors. Based on FDA recall #D-1516-201 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1516-201%22&limit=1).
Why it’s dangerous
The hazard stems from labeling errors where the lot number and/or expiration date are incorrect or missing. This can make it difficult for patients and pharmacists to verify the medication's freshness and traceability, potentially leading to the use of expired drugs or confusion about product authenticity.
Who’s affected
Consumers who purchased 100-count bottles of prescription Escitalopram Tablets USP 20 mg manufactured by Lupin Limited. The risk is primarily related to medication management confusion due to unclear expiration dates rather than immediate physical harm.
How to tell if you have this one
Check your bottle of Escitalopram Tablets USP 20 mg (Rx Only) for NDC 68180-136-01. Look specifically at the label for Lot # G510086 and an expiration date of 11/17. Verify that the manufacturer is listed as Lupin Limited, Goa 403 722, India.
- Brand
Lupin- Category
Drug
What to do — step by step
Check Your Bottle
Verify if your bottle matches NDC 68180-136-01 with Lot # G510086 and Exp. 11/17.
Contact Your Pharmacist
If you have the recalled product, speak with your pharmacist or healthcare provider for guidance on replacement or disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many bottles are affected by this recall?
The recall involves 3,192 bottles, containing a total of 319,200 tablets.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1516-201 (March 24, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1516-201 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.